The agency wants applicants to demystify their algorithms and provide specific details about what the models do, how they’re ...

Stay updated on the volatile share price of Recursion, a biotech company with a maturing pipeline and potential for growth ...

Over a video call, Alex Zhavoronkov holds up a small, green, diamond-shaped pill. It has been developed by his company to ...

A middle school student in Chicago made headlines by uncovering a remarkable medical breakthrough hidden in a surprising ...

Our fair value estimate for WuXi is HKD 24.60 per share. WuXi has been growing at a CAGR of 53.3% for the past eight years. Although its USD 20.5 billion total backlog revenue supports our growth ...

With the intensification of global population aging, muscle atrophy, characterized by the loss of muscle mass and function, has become an important health issue affecting the elderly. Researchers have ...

This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and ...

AMD's technology will also be used to boost Absci's drug discovery workload, including the company's de novo antibody design ...

Drug discovery is a key area for AI, given the speed at which models trained on massive datasets can tackle a variety of tasks. Last year, Nvidia said it was doubling down on AI-powered drug discovery ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process ...